Group One Trading’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-200
| Closed | -$282 | – | 8454 |
|
|
2023
Q2 | $282 | Hold |
200
| – | – | ﹤0.01% | 7435 |
|
|
2023
Q1 | $318 | Buy |
+200
| New | +$363 | ﹤0.01% | 6955 |
|
|
2022
Q1 | – | Sell |
-38,400
| Closed | -$140K | – | 8881 |
|
|
2021
Q4 | $140K | Buy |
38,400
+10,000
| +35% | +$53.4K | ﹤0.01% | 5432 |
|
|
2021
Q3 | $228K | Buy |
28,400
+8,100
| +40% | +$79.8K | ﹤0.01% | 5034 |
|
|
2021
Q2 | $230K | Buy |
20,300
+300
| +2% | +$3.01K | ﹤0.01% | 5089 |
|
|
2021
Q1 | $185K | Buy |
+20,000
| New | +$208K | ﹤0.01% | 5104 |
|
|
2020
Q2 | – | Sell |
-163
| Closed | -$2K | – | 6285 |
|
|
2020
Q1 | $2K | Buy |
+163
| New | +$3.54K | ﹤0.01% | 5015 |
|
|
2019
Q3 | – | Sell |
-143
| Closed | -$4K | – | 5656 |
|
|
2019
Q2 | $4K | Buy |
+143
| New | +$5.53K | ﹤0.01% | 4658 |
|
|
2019
Q1 | – | Sell |
-314
| Closed | -$5K | – | 5474 |
|
|
2018
Q4 | $5K | Sell |
314
-1,023
| -77% | -$41.8K | ﹤0.01% | 4486 |
|
|
2018
Q3 | $94K | Buy |
1,337
+794
| +146% | +$60.3K | ﹤0.01% | 3585 |
|
|
2018
Q2 | $40K | Sell |
543
-211
| -28% | -$18.8K | ﹤0.01% | 4066 |
|
|
2018
Q1 | $72K | Buy |
754
+637
| +544% | +$109K | ﹤0.01% | 3455 |
|
|
2017
Q4 | $15K | Buy |
+117
| New | +$11K | ﹤0.01% | 4261 |
|
|
2017
Q1 | – | Sell |
-1,586
| Closed | -$201K | – | 5082 |
|
|
2016
Q4 | $201K | Hold |
1,586
| – | – | ﹤0.01% | 2419 |
|
|
2016
Q3 | $243K | Buy |
1,586
+1,364
| +614% | +$193K | ﹤0.01% | 2325 |
|
|
2016
Q2 | $26K | Sell |
222
-16
| -7% | -$1.77K | ﹤0.01% | 3676 |
|
|
2016
Q1 | $27K | Sell |
238
-173
| -42% | -$26.2K | ﹤0.01% | 3599 |
|
|
2015
Q4 | $77K | Buy |
411
+179
| +77% | +$33.5K | ﹤0.01% | 3157 |
|
|
2015
Q3 | $39K | Buy |
232
+41
| +21% | +$14.8K | ﹤0.01% | 3683 |
|
|
2015
Q2 | $121K | Sell |
191
-101
| -35% | -$53.7K | ﹤0.01% | 2933 |
|
|
2015
Q1 | $150K | Sell |
292
-130
| -31% | -$65.6K | ﹤0.01% | 2600 |
|
|
2014
Q4 | $226K | Sell |
422
-1,810
| -81% | -$816K | ﹤0.01% | 2211 |
|
|
2014
Q3 | $3.35M | Buy |
2,232
+1,685
| +308% | +$2.44M | 0.05% | 440 |
|
|
2014
Q2 | $749K | Buy |
547
+56
| +11% | +$65K | 0.01% | 1339 |
|
|
2014
Q1 | $681K | Buy |
491
+431
| +718% | +$501K | 0.01% | 1399 |
|
|
2013
Q4 | $60K | Buy |
60
+58
| +2,900% | +$60K | ﹤0.01% | 3466 |
|
|
2013
Q3 | $2K | Sell |
2
-283
| -99% | -$302K | ﹤0.01% | 4973 |
|
|
2013
Q2 | $312K | Buy |
+285
| New | +$318K | 0.01% | 1760 |
|
Other funds holding VIRX
BI
LCM
SB
MCM
ACM
Group One Trading's VIRX Position: Q3 2023 in Review
Group One Trading sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2023, closing a stake of 100 shares — an estimated $141 sold.
Group One Trading first reported a position in VIRX in Q2 2013 and held it in 35 quarters. The position peaked at $564K in Q2 2015. 42 funds tracked by Wall St. Rank hold VIRX as of Q3 2023.
- Group One Trading reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Group One Trading sold 100 Viracta Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $141.
- Group One Trading first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
- Group One Trading's Viracta Therapeutics, Inc. Common Stock position peaked at $564K in Q2 2015.
- 42 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.